First look: testing a schizophrenia drug in teens
NCT ID NCT04779177
Summary
This study tested the safety and how the body processes a medication called lumateperone in teenagers with schizophrenia or schizoaffective disorder. It involved 26 participants aged 13 to 17. The main goal was to understand the drug's side effects and how it moves through the body in this younger age group.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site
Hollywood, Florida, 33024, United States
-
Clinical Site
Atlanta, Georgia, 30331, United States
-
Clinical Site
Decatur, Georgia, 30030, United States
Conditions
Explore the condition pages connected to this study.